We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

16 hedge funds and large institutions have $6.17M invested in Parnell Pharmaceuticals Holdings Ltd in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7% more funds holding

Funds holding: 15 → 16 (+1)

47% less capital invested

Capital invested by funds: $11.5M → $6.17M (-$5.37M)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BA
BlackRock Advisors
Delaware
+$41.3K
2
VKH
Virtu KCG Holdings
New York
+$33.9K
3
AP
Atwood & Palmer
Missouri
+$19K
4
Deutsche Bank
Deutsche Bank
Germany
+$10.6K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.06K

Top Sellers

1
ECM
Endurant Capital Management
California
-$137K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$119K
3
BIM
BlackRock Investment Management
Delaware
-$71.2K
4
BG
BlackRock Group
United Kingdom
-$50.5K
5
Goldman Sachs
Goldman Sachs
New York
-$49.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.82M – – –
BA
2
BlackRock Advisors
Delaware
$1.23M +$41.3K +14,947 +3%
AG
3
Artal Group
Luxembourg
$1.06M – – –
ECM
4
Endurant Capital Management
California
$822K -$137K -49,725 -11%
BG
5
BlackRock Group
United Kingdom
$452K -$50.5K -18,312 -8%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$314K -$119K -43,043 -23%
BlackRock
7
BlackRock
New York
$240K -$6.39K -2,315 -2%
BIM
8
BlackRock Investment Management
Delaware
$133K -$71.2K -25,800 -29%
Goldman Sachs
9
Goldman Sachs
New York
$34K -$49.6K -17,983 -53%
VKH
10
Virtu KCG Holdings
New York
$26K +$33.9K +12,285 New
AP
11
Atwood & Palmer
Missouri
$15K +$19K +6,900 New
Deutsche Bank
12
Deutsche Bank
Germany
$8K +$10.6K +3,824 New
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$4K – – –
AA
14
AlphaMark Advisors
Kentucky
$2K – – –
Morgan Stanley
15
Morgan Stanley
New York
$2K +$1.38K +500 +96%
TRCT
16
Tower Research Capital (TRC)
New York
$2K +$2.06K +747 +249%
UBS Group
17
UBS Group
Switzerland
– -$4K -1,071 Closed
Walleye Trading
18
Walleye Trading
New York
– -$1K -200 Closed

PARN Hedge Fund Activity: Q1 2016 in Review

16 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q1 2016, worth a combined $6.17M — down 47% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PARN positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $41.3K. The largest seller was Endurant Capital Management, cutting an estimated $137K.

  • 16 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q1 2016, up from 15 in Q4 2015.
  • Funds reported $6.17M of Parnell Pharmaceuticals Holdings Ltd stock for Q1 2016, down 47% quarter-over-quarter.
  • 3 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q1 2016 and 2 closed out, a net change of +1 holder.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q1 2016 was BlackRock Advisors, an estimated $41.3K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q1 2016 was Endurant Capital Management, an estimated $137K sold.

Based on aggregated 13F filings for Q1 2016.